Detalhe da pesquisa
1.
Therapeutic Approaches With Immune Checkpoint Inhibitors in Head and Neck Cancers and the Role of PD-L1 as a Biomarker.
Cancer Control
; 28: 10732748211004878, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33827280